Bacteria · Genus

Bifidobacterium

Beneficial   Beneficial, fibre-loving bacteria and a common probiotic target; abundant in breastfed infants and broadly protective.

Associated with these conditions
Celiac disease Reduced

Lower Bifidobacterium is repeatedly reported and is a probiotic target under study.

Moderate evidence

Scarcity of protective Bifidobacterium precedes disease; probiotics reduce NEC risk in preterm infants.

Moderate evidence

Low infant Bifidobacterium repeatedly precedes eczema — central to the ‘old friends’ hypothesis.

Moderate evidence
Food allergy Reduced

Depleted protective taxa (Bifidobacterium and Clostridia) accompany allergic sensitization.

Preliminary
Type 1 diabetes Elevated

Reported in Disbiome, HMDAD (1 cited study).

Moderate evidence
Cirrhosis Associated with

Reported in Disbiome.

Preliminary
Obesity Associated with

Reported in Disbiome.

Preliminary
Hepatitis B Associated with

Reported in Disbiome.

Preliminary
Lung cancer Associated with

Reported in Disbiome.

Preliminary
Asthma Associated with

Reported in Disbiome.

Preliminary
Silicosis Associated with

Reported in Disbiome.

Preliminary
Cholestasis Associated with

Reported in Disbiome.

Preliminary
Smoking Associated with

Reported in Disbiome.

Preliminary
Psoriasis Associated with

Reported in Disbiome.

Preliminary
Acne Associated with

Reported in Disbiome.

Preliminary
Diarrhea Associated with

Reported in Disbiome, Peryton.

Moderate evidence
Alcoholism Associated with

Reported in Disbiome.

Preliminary
What shifts it
Iron Lowers it
Nutrient
Moderate evidence Well-established
Antibiotics Lowers it
Medication
Well-replicated Well-established
Helps make
‹ All organisms